Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: Lessons from obesity, diabetes and psoriasis Academic Article uri icon

Overview

MeSH Major

  • Diabetes Mellitus, Type 2
  • Glucagon-Like Peptide 1
  • Natural Killer T-Cells
  • Psoriasis
  • Receptors, Glucagon

abstract

  • The clinical effect observed and the direct interaction between GLP-1 and the immune system raise the possibility of therapeutic applications for GLP-1 in inflammatory conditions such as psoriasis.

publication date

  • November 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3188710

Digital Object Identifier (DOI)

  • 10.1007/s00125-011-2232-3

PubMed ID

  • 21744074

Additional Document Info

start page

  • 2745

end page

  • 54

volume

  • 54

number

  • 11